Oral Hygiene Assistance Training Program

NCT07807397 — Phase 4, Not yet recruiting, 500 participants, Colgate Palmolive

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07807397
StatusNot yet recruiting
PhasePhase 4
Study typeInterventional; non randomized, parallel, masking: none, treatment
Enrollment500 (Estimated)
SponsorColgate Palmolive (Industry); collaborators: McCoy Samples Mattingly Dental Clinic, FENO.Co
ConditionsElderly, Periodontal Disease, Gingivitis, Caries,Dental
InterventionsStannous Fluoride Toothpaste (SnF), sodium fluoride 5000 ppm, cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash, sodium fluoride Mouthwash, Chlorhexidine 0,12%, connected toothbrush, xylitol toothpaste (Drug, device, other)
Datesstart 2026-09-20 (estimated), primary completion 2027-09-01 (estimated), completion 2027-09-01 (estimated), first posted 2026-09-08, last updated 2026-09-08

Related Papers Related Patents Related Grants Related Experts
All trials for Elderly All trials for Periodontal Disease All trials of Stannous Fluoride Toothpaste (SnF) All trials of sodium fluoride 5000 ppm

-Summary

This is an oral health study with a nursing home staff training program and product intervention.

Expand all sections  ·  Collapse all

+Detailed description

This study will be completed in partnership with the Missouri Department of Health and Senior Services, McCoy Samples Mattingly Dental Clinic, and Feno, inc. The study involves a nursing home staff training program, product intervention, and oral health outcomes.

+Arms and interventions

ArmTypeInterventionsDescription
Cohort AExperimentalDrug: Stannous Fluoride Toothpaste (SnF); Drug: sodium fluoride 5000 ppm; Drug: cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash; Drug: sodium fluoride Mouthwash; Drug: Chlorhexidine 0,12%Subjects in this arm of the trial will use a manual or power toothbrush, OTC and/or Rx toothpaste, and OTC and/or Rx mouthwash.
Cohort BExperimentalDrug: sodium fluoride Mouthwash; Drug: Chlorhexidine 0,12%; Device: connected toothbrush; Other: xylitol toothpasteSubjects in this arm of the trial will use a smart toothbrush, a cosmetic toothpaste, and an OTC and/or Rx mouthwash.
  • Stannous Fluoride Toothpaste (SnF) (Drug): Cohort A will use a stannous fluoride toothpaste
  • sodium fluoride 5000 ppm (Drug): Cohort A will have the option of using a sodium fluoride 5000 ppm toothpaste if prescribed by the dentist.
  • cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash (Drug): Cohort A will use an antiplaque/antigingivitis mouthwash
  • sodium fluoride Mouthwash (Drug): Cohort A and Cohort B may use the sodium fluoride OTC mouthwash
  • Chlorhexidine 0,12% (Drug): Cohort A and Cohort B may use a 0.12% chlorhexidine alcohol free mouthwash
  • connected toothbrush (Device): Cohort B will use a u-shaped connected "smart" toothbrush
  • xylitol toothpaste (Other): Cohort B will use a xylitol toothpaste

+Outcome measures

Primary outcomes

  • Incidence of pneumonia [1 year]: Incidence of pneumonia acquired during the study

Secondary outcomes

  • Diabetes status [every 3 months for 1 year]
  • HbA1c value [Every 3 months for 1 year]
  • Oral Health History [Baseline]: Significant history of oral health
  • Oral Health Status [Monthly for one year]: This includes plaque, calculus, stain, visible inflammation, and oral hygiene status
  • Level of adherence to oral hygiene regimen [Monthly for 1 year]: This is a measure of how adherent the nursing home staff was in completing each instance of oral hygiene regimens for the subjects.
  • Satisfaction with program [1 year]: This will be captured via surveys for the subjects, facility staff, and facility leadership at different times throughout the study.

+Eligibility

Sex: All, ages: 60 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Signed Informed Consent Form to receive on-site dental care and grant access to their medical and dental records, and Consent for information collection, consultation, and disease control oral healthcare treatment
* Male and female subjects aged 60 years or older.
* A resident of one of the nursing home sites.
* ASA physical classification status of II, III, or IV (excluding high frailty scores)
* Frailty assessment of low or moderate

Exclusion Criteria:

* Tumor(s) of the soft or hard tissues of the oral cavity.
* History of allergies to oral care/personal care consumer products or their ingredients.
* ASA category V patients
* High frailty assessment
* Resident deemed behaviorally difficult in interview or initial assessment
* Endentulous
* Fractured teeth and/or root tips present
* Oral lesions
* Grossly mobile teeth for Cohort B
* Temporary crowns for Cohort B